4.6 Article

Thrombin-Activatable Fibrinolysis Inhibitor Protects against Acute Lung Injury by Inhibiting the Complement System

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Acute Respiratory Distress Syndrome The Berlin Definition

V. Marco Ranieri et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Public, Environmental & Occupational Health

Acute respiratory distress syndrome: epidemiology and management approaches

Allan Walkey et al.

Clinical Epidemiology (2012)

Review Pathology

The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

Michael A. Matthay et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

Article Critical Care Medicine

Biomarkers in Acute Lung Injury: Insights into the Pathogenesis of Acute Lung Injury

L. J. Mark Cross et al.

CRITICAL CARE CLINICS (2011)

Article Biochemistry & Molecular Biology

Therapeutic Modulation of Coagulation and Fibrinolysis in Acute Lung Injury and the Acute Respiratory Distress Syndrome

Sara C. Sebag et al.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)

Article Biochemistry & Molecular Biology

An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis

Evelien Heylen et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2011)

Article Physiology

Complement levels and activity in the normal and LPS-injured lung

Molly S. Bolger et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)

Article Medicine, General & Internal

Incidence and outcomes of acute lung injury

GD Rubenfeld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Biochemistry & Molecular Biology

Targeting C5a: Recent advances in drug discovery

M Allegretti et al.

CURRENT MEDICINAL CHEMISTRY (2005)

Article Immunology

Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N

WD Campbell et al.

MICROBIOLOGY AND IMMUNOLOGY (2002)